Zobrazeno 1 - 7
of 7
pro vyhledávání: '"John Umejiego"'
Autor:
Charles M. Rudin, Martin Reck, Melissa L. Johnson, Fiona Blackhall, Christine L. Hann, James Chih-Hsin Yang, Julie M. Bailis, Gwyn Bebb, Amanda Goldrick, John Umejiego, Luis Paz-Ares
Publikováno v:
Journal of Hematology & Oncology, Vol 16, Iss 1, Pp 1-21 (2023)
Abstract Small cell lung cancer (SCLC) is an aggressive neuroendocrine carcinoma with a poor prognosis. Initial responses to standard-of-care chemo-immunotherapy are, unfortunately, followed by rapid disease recurrence in most patients. Current treat
Externí odkaz:
https://doaj.org/article/10e1da2e3d234f1e801863a73f93ec88
Autor:
James Yao, Emily Bergsland, Rahul Aggarwal, Ana Aparicio, Himisha Beltran, Judy S Crabtree, Christine L Hann, Toni Ibrahim, Lauren A Byers, Hironobu Sasano, John Umejiego, Marianne Pavel
Publikováno v:
The Oncologist. 27:940-951
Introduction Neuroendocrine neoplasms (NEN) are heterogeneous malignancies that can arise at almost any anatomical site and are classified as biologically distinct well-differentiated neuroendocrine tumors (NET) and poorly differentiated neuroendocri
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::53db8978588d60bfb47c86fc4d2b1743
https://doi.org/10.1093/oncolo/oyac161
https://doi.org/10.1093/oncolo/oyac161
Autor:
Alessandro Pontes-Arruda, John Umejiego, Robert S. Rosenson, Emily B. Levitan, Ligong Chen, Parag Goyal
Publikováno v:
Circulation. 142
Introduction: While there are data demonstrating poor outcomes associated with discontinuation of renin-angiotensin system inhibitors (RASI) after hospitalization for heart failure with reduced ejection fraction (HFrEF), less is known about the preva
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6fa6a434090153ee6ddf4ec893192819
https://doi.org/10.1161/circ.142.suppl_3.13942
https://doi.org/10.1161/circ.142.suppl_3.13942
Autor:
Sarah S. Cohen, Quinn S. Wells, Ricardo Dent, Eric Farber-Eger, Loren Lipworth, John Umejiego, Paul J. Dluzniewski
Publikováno v:
Journal of Cardiac Failure. 26:S82
Introduction Heart failure with reduced ejection fraction (HFrEF) incurs significant mortality, morbidity and cost. Despite recent advances, opportunities for therapeutic improvement remains. Omecamtiv mecarbil (OM) is a first-in-class cardiac myotro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0b5ac5919faee40420b1266011777d32
https://doi.org/10.1016/j.cardfail.2020.09.238
https://doi.org/10.1016/j.cardfail.2020.09.238
Autor:
Marcelo Fernandez-Vina, John Umejiego, Michael Haagenson, Minoo Battiwalla, E. Victoria Turner, Medhat Askar, Ann E. Woolfrey, Lee Ann Baxter-Lowe, Tao Wang, Effie W. Petersdorf, Kirk R. Schultz, Edmund K. Waller, Steven G.E. Marsh, Michelle Setterholm, Mahmoud Aljurf, Machteld Oudshoorn, Stephen R. Spellman, Susana R. Marino, Stephanie J. Lee, James Gajewski, Ann A. Jakubowski
Publikováno v:
Blood. 123:1270-1278
In subjects mismatched in the HLA alleles C*03:03/C*03:04 no allogeneic cytotoxic T-lymphocyte responses are detected in vitro. Hematopoietic stem cell transplantation (HSCT) with unrelated donors (UDs) showed no association between the HLA-C allele
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::76b06ce520a90dd4239b226e0f71fc56
https://doi.org/10.1182/blood-2013-10-532671
https://doi.org/10.1182/blood-2013-10-532671
Autor:
Edmund K. Waller, Alison W. Loren, Mitchell S. Cairo, Robert Peter Gale, Hillard M. Lazarus, Alan M. Miller, Biju George, Jane L. Liesveld, John Umejiego, Edward A. Copelan, Harry C. Schouten, Hai-Lin Wang, David A. Rizzieri, Daniel J. Weisdorf, Bruce M. Camitta, Bipin N. Savani, Barry E. Storer, Mark R. Litzow, Corey Cutler, Stephanie J. Lee, H. Jean Khoury, David I. Marks, Vikas Gupta, Thomas R. Klumpp, Luis Isola, Jean-Yves Cahn
Publikováno v:
Biology of Blood and Marrow Transplantation, 19(11), 1600-1607. Elsevier Science
Biology of Blood and Marrow Transplantation
Biology of Blood and Marrow Transplantation, Elsevier, 2013, 19 (11), pp.1600-7. ⟨10.1016/j.bbmt.2013.08.013⟩
Biology of Blood and Marrow Transplantation
Biology of Blood and Marrow Transplantation, Elsevier, 2013, 19 (11), pp.1600-7. ⟨10.1016/j.bbmt.2013.08.013⟩
International audience; Prediction of subsequent leukemia-free survival (LFS) and chronic graft-versus-host disease (GVHD) in adults with acute leukemia who survived at least 1 year after allogeneic hematopoietic cell transplantation is difficult. We
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1a4d4003845fce1986dcac676309d686
https://doi.org/10.1016/j.bbmt.2013.08.013
https://doi.org/10.1016/j.bbmt.2013.08.013
Autor:
Wael Saber, John Umejiego, Joseph Pidala, Ann E. Woolfrey, Mahmoud Aljurf, Carolyn Katovich Hurley, John T. Horan, Machteld Oudshoorn, Minoo Battiwalla, Medhat Askar, Stephen R. Spellman, Michael Haagenson, Victoria Turner, Tao Wang, Stephanie J. Lee, Jason Dehn
Publikováno v:
Blood. 121:4800-4806
The impact of HLA homozygosity at mismatched (MM) loci on the outcome of 2687 myeloablative unrelated donor hematopoietic cell transplantations performed for malignant disease was evaluated among 4 groups: 7/8 bidirectional MM transplants (donor and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5682b61600fb9c3a67795a6d11be8343
https://doi.org/10.1182/blood-2013-01-480343
https://doi.org/10.1182/blood-2013-01-480343